PRISM BIOLAB CO., LTD.
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd. 2025-11-14 16:00
Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting 2025-05-23 08:00
PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets 2025-04-14 15:00
PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono 2024-04-25 14:00
PRISM BioLab raises 1.5 billion yen in Series C fundraising to advance technologies and programs targeting protein-protein interactions 2024-01-24 16:00
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target 2023-11-29 04:01
PRISM BioLab, enters multi-project drug discovery collaboration with Roche and Genentech 2022-01-05 09:00
1